Patrys (ASX:PAB) has started key manufacturing and regulatory activities for the advancement of RLS-2201, the company’s proprietary injectable formulation of Quetiapine being developed to alleviate ...

Opioids have been used for hundreds of years to treat restless leg syndrome (RLS), but there is currently a registry to understand the long-term effectiveness of opioids to treat RLS , said John ...